Status:
COMPLETED
tDCS for Fatigue in Sjogren's Syndrome
Lead Sponsor:
Federal University of São Paulo
Collaborating Sponsors:
University of Pittsburgh
Universidade Federal do Amapá
Conditions:
Sjogren's Syndrome
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Sjogren's Syndrome (SS) is an autoimune disease of unknown etiology characterized by lymphocytic infiltration of the exocrine glands and other organs. patients usually presents with xerophthalmia, xer...
Eligibility Criteria
Inclusion
- Women
- Age between 18 and 65 years old;
- Diagnosis of primary Sjogren's Syndrome according to American-European Criteria;
- Stable pharmacological therapy for at least 3 months;
- Complaints of fatigue as assessed by Fatigue Severity Scale (FSS\>5).
- Complaints of fatigue for more than 3 months.
Exclusion
- Heart, coronary, respiratory, renal, or hepatic uncompensated insufficiencies;
- Uncompensated systemic arterial hypertension;
- Unable to answer the questionnaires.
- Severe depression (with a score \> 30 in the Beck Depression Inventory)
- History of epilepsy or syncope
- Implanted brain metallic devices
- Established cognitive impairment
- Traumatic brain injury with residual neurological deficits
Key Trial Info
Start Date :
June 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04119128
Start Date
June 3 2019
End Date
April 1 2020
Last Update
May 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FUSaoPaulo
São Paulo, São Paulo, Brazil, 04024-002